Gustafsson et al., found that sAxl levels in patients with renal cell carcinoma (RCC) were lower than in healthy controls, did not correlate with tumor Axl expression, nor tumor size [20]. This evidence concerns the gene AXL and hereditary clear cell renal cell carcinoma.